Targeting apoptosis pathways in cancer therapy

Ämnen: Hämta fulltext
Series

Targeting apoptosis pathways in cancer therapy

Ämnen: Hämta fulltext
Series

Therapy in cancer 2008 quo vadis? /

Ämnen: Hämta fulltext
Series

Emerging trends in phase II trial design

Ämnen: Hämta fulltext
Series

Small molecule inhibitors of receptor tyrosine kinases

Ämnen: Hämta fulltext
Series

Cytotoxic chemotherapy

Ämnen: Hämta fulltext
Series

Clinical applications of molecular imaging imaging to guide cancer therapy /

Ämnen: Hämta fulltext
Series

Putting evidence into practice : Improving oncology patient outcomes.

Ämnen:

Putting evidence into practice : Improving oncology patient outcomes /

Ämnen:

The challenge of targeting toxins to tumors

Ämnen: Hämta fulltext
Series

Checkpoint blockade in cancer immunotherapy

Ämnen: Hämta fulltext
Series

Cancer pain and related symptoms an overview /

Ämnen: “…Neoplasms therapy. 112937…”
Hämta fulltext
Series

Chronic cancer pain the price of success? /

Ämnen: “…Neoplasms therapy. 112983…”
Hämta fulltext
Series

RNA interference and cancer a revolution? /

Ämnen: Hämta fulltext
Series

Phase III trials

Ämnen: Hämta fulltext
Series

EGFR inhibitors in NSCLC and the role of biomarkers for selection of patients

Ämnen: Hämta fulltext
Series

Germline pharmacogenomics as a tool to individualize therapy in breast cancer

Ämnen: Hämta fulltext
Series

Immune checkpoint blockade and head and neck cancer

Ämnen: Hämta fulltext
Series

Celiac plexus block

Ämnen: Hämta fulltext
Series

Insight and responsibility ethics in pain medicine and palliative care /

Ämnen: Hämta fulltext
Series